Ophthalmic Devices - Southeast Asia

The Ophthalmic Devices market market in Southeast Asia is estimated to achieve a revenue of US$970.00m by 2024.
It is anticipated to experience a steady annual growth rate (CAGR 2024-2029) of 7.73%, leading to a market volume of US$1.41bn by 2029.
When compared on a global scale, the United States is expected to generate the highest revenue with US$14.00bn in 2024.
In Southeast Asia, the demand for advanced ophthalmic devices is rapidly increasing, driven by the region's aging population and the rising prevalence of eye diseases.

Definition:
Ophthalmic devices refer to medical devices used for diagnosis of eye diseases, related surgeries, and vision correction.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Essilor International, Johnson & Johnson, Bausch Health Companies. Further information on the key players can be found in the Market Shares boxes.

Ophthalmology diagnostic & surgical devices
Vision care

Ophthalmology pharmaceuticals
Ophthalmology supplements

The Ophthalmic Devices market in Southeast Asia is experiencing significant growth due to increasing customer preferences for advanced eye care solutions, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Southeast Asia are driving the demand for ophthalmic devices. With a growing middle class and increasing disposable income, customers are becoming more aware of eye health and are seeking advanced eye care solutions. They are willing to invest in high-quality ophthalmic devices that can provide accurate and reliable diagnosis and treatment options. Additionally, the rising prevalence of eye diseases and disorders, such as cataracts and glaucoma, is further fueling the demand for ophthalmic devices in the region. Trends in the market are also contributing to the growth of the Ophthalmic Devices market in Southeast Asia. Technological advancements in ophthalmic devices, such as the development of innovative imaging techniques and minimally invasive surgical procedures, are revolutionizing the field of ophthalmology. These advancements are enabling healthcare professionals to provide more accurate diagnoses and treatments, resulting in improved patient outcomes. Moreover, the increasing adoption of telemedicine and remote monitoring technologies is facilitating access to eye care services in remote areas, where access to healthcare facilities may be limited. Local special circumstances in Southeast Asia are also playing a role in the development of the Ophthalmic Devices market. The region has a large aging population, which is more prone to age-related eye diseases and disorders. This demographic trend is driving the demand for ophthalmic devices, such as intraocular lenses and surgical instruments, for cataract surgeries and other age-related eye conditions. Additionally, the high prevalence of diabetes in Southeast Asia is increasing the risk of diabetic retinopathy, further boosting the demand for ophthalmic devices for early detection and treatment. Underlying macroeconomic factors are also contributing to the growth of the Ophthalmic Devices market in Southeast Asia. The region is experiencing rapid economic growth, leading to an expansion of healthcare infrastructure and an increase in healthcare spending. Governments in Southeast Asian countries are investing in the development of healthcare facilities and promoting medical tourism, attracting patients from neighboring countries for eye care treatments. Moreover, the growing medical tourism industry is driving the demand for ophthalmic devices, as international patients seek advanced eye care treatments in the region. In conclusion, the Ophthalmic Devices market in Southeast Asia is growing due to increasing customer preferences for advanced eye care solutions, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The region's rising middle class, technological advancements, aging population, high prevalence of eye diseases, and economic growth are all contributing to the development of the market. As the demand for ophthalmic devices continues to increase, manufacturers and healthcare providers in Southeast Asia have significant opportunities for growth and expansion.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.